Results 121 to 130 of about 950,583 (268)
COMPARISON OF HCV RNA AND HCV CORE ANTIGEN IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS [PDF]
, 2014 Ankarali, Handan Camdeviren/0000-0002-3613-0523; Karabay, Oguz/0000-0003-0502-432XWOS: 000364114800009Background: Anti-HCV test is currently used in the diagnosis of hepatitis C, while hepatitis C virus ribonucleic acid (HCV RNA) is used in the ...Özdemir, Fatma, Öğütlü, Aziz, Ankaralı, Handan, Karabay, Meltem, Gözdaş, Hasan Tahsin, Karabay, Oğuz +5 morecore +2 more sourcesLongitudinal changes in readily available inflammatory markers before and after switching to integrase inhibitor‐based antiretroviral therapy in Virologically suppressed people living with HIV: A Nationwide real‐world cohort study
HIV Medicine, EarlyView.Abstract Background
Persistent immune activation and systemic inflammation remain key features of chronic HIV infection despite sustained virological suppression under antiretroviral therapy (ART), contributing to excess non‐AIDS morbidity and mortality.Stelios F. Assimakopoulos, Achilleas Stamoulopoulos, Mina Psichogiou, Varvara Vasalou, Vasileios Papastamopoulos, Antonis Papadopoulos, Georgios Adamis, Maria Chini, Simeon Metallidis, Georgios Loizos, Lydia Leonidou, Helen Sambatakou, Markos Marangos, Diamantis Kofteridis, Giota Touloumi, on behalf of AMACS, G. Adamis, M. Chini, G. Chrysos, M. Marangos, O. Katsarou, D. Kofteridis, S. Metallidis, P. Panagopoulos, N. Pantazis, A. Papadopoulos, V. Paprizos, V. Papastamopoulos, M. Psichogiou, H. Sambatakou, NV. Sipsas, G. Touloumi, G. Touloumi, N. Pantazis, C. Thomadakis, A Stamoulopoulos, A Papadopoulos, A Antoniadou, C Protopapas, D Kavatha, G Chrysos, T Nitsotolis, M Psichogiou, E Mastrogianni, G Adamis, M Astriti, MN Marangos, L Leonidou, O Katsarou, A Kouramba, NV Sipsas, A Kontos, D Basoulis, M Chini, G Tsekes, N Mangafas, S Metallidis, O Tsachouridou, Τ Chrysanthidis, V Paparizos, V Vasalou, S Kourkounti, H Sambatakou, V Papastamopoulos, G Lourida, P Panagopoulos, V Petrakis, D Kofteridis, K Alexakis, V Malikidis, H Gogos, M Psichogiou +71 morewiley +1 more sourcePatterns of hepatitis C virus RNA levels during acute infection: the InC3 study.
PLoS ONE, 2015 BackgroundUnderstanding the patterns of HCV RNA levels during acute hepatitis C virus (HCV) infection provides insights into immunopathogenesis and is important for vaccine design.Behzad Hajarizadeh, Bart Grady, Kimberly Page, Arthur Y Kim, Barbara H McGovern, Andrea L Cox, Thomas M Rice, Rachel Sacks-Davis, Julie Bruneau, Meghan Morris, Janaki Amin, Janke Schinkel, Tanya Applegate, Lisa Maher, Margaret Hellard, Andrew R Lloyd, Maria Prins, Gregory J Dore, Jason Grebely, InC3 Study Group +19 moredoaj +1 more sourceHCV RNA and age of infection.
, 2014 HCV RNA and age of infection.Ashwin Balagopal (19837), Ruy M. Ribeiro (46390), David L. Thomas (147124), Stuart C. Ray (530234), Frederik Graw (175938), Abraham J. Kandathil (660110), Alan S. Perelson (140160) +6 morecore +1 more sourcePregnancy and neonatal outcomes after prenatal exposure to dolutegravir: Data from a European cohort collaboration
HIV Medicine, EarlyView.Abstract Objective
We aimed to assess ‘real‐world’ pregnancy and neonatal outcomes following prenatal dolutegravir (DTG) use in a European setting. Methods
We conducted a pooled analysis of individual‐patient data from seven observational studies. Pregnancies with DTG exposure any time from the periconception period (≤6 completed gestational weeks ...Rebecca Sconza, Georgina Fernandes, Virginia Rasi, Heather Bailey, Karoline Aebi‐Popp, Luminita Ene, Marco Floridia, Anna Gamell, Marta Illán Ramos, Helen Peters, Anna Samarina, Giorgia Dalla Valle, Gabija Morkunaite, Carlo Giaquinto, Leigh Ragone, Annemiek de Ruiter, Vani Vannappagari, Claire Thorne, on behalf of the DOLOMITE‐EPPICC Group, Claudia Fortuny, Christian Kahlert, Luis Manuel Prieto Tato, José Tomás Ramos Amador +22 morewiley +1 more sourcePrevalence of HPgV-2 RNA in HCV and non-HCV infected groups.
, 2015 *P-value of differences in HPgV-2 RNA (top) and antibody (bottom) prevalence between reference and comparison groups. Index case (HCV Ab+ /NAT+) has been excluded from totals screened.Prevalence of HPgV-2 RNA in HCV and non-HCV infected groups.Matthew Frankel (836755), Kevin Cheng (836757), Catherine Brennan (836761), Kelly Coller (836754), Donald M. Jensen (836762), Marilee Marcinkus (836759), Charles Y. Chiu (123228), Samia N. Naccache (408011), Deanna Lee (131474), Kenn Forberg (836758), George Dawson (836760), Michael G. Berg (829733), Andrew Aronsohn (836756), John Hackett Jr. (836763) +13 morecore +1 more sourcePreventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement
Internal Medicine Journal, EarlyView.Abstract
Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.Aine Hurley, Philip George, Gemma Reynolds, Adam Stewart, Hang Quach, Nicole O'Leary, Zoe McQuilten, Andrea S. Henden, Lynette Chee, Chan Y. Cheah, Olivia Bupha‐Intr, Emily Blyth, Ben Teh, Monica Slavin, Michael Dickinson, Robert Weinkove +15 morewiley +1 more sourceHCV RNA载量与肝脏组织损伤的关系
Zhongguo shiyan zhenduanxue, 2011 目的探讨丙型肝炎病毒(HCV)RNA复制水平与肝功能丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)之间的相互关系。方法收集1182例疑似丙肝病人血清标本,采用荧光定量聚合酶链反应(FQ-PCR)检测HCV RNA,利用酶动力法测定ALT、AST,采用ELISA测定抗HCV抗体。数据采用SPSS16.0统计软件处理。结果病人血清样本中,HCV RNA阳性801例(64.8%),其中抗HCV阳性766例(95.6%);HCV RNA阴性381例(32.2%),其中抗HCV阳性100例(26.2%)丁柳, 周易, 宋兴勃, 叶远馨, 陆小军, 张磊, 应斌武 +6 moredoaj NGS of HCV biopsy RNA.
, 2013 Extracted and pooled (×6) HCV infected biopsy RNA was reverse transcribed and amplified prior to Illumina NGS and mapped to the HCV reference 3a.NZL. NC_0009824 (Los Alamos HCV database).Paul Kellam (6413), Sam Stubbs (336836), Gordon M. Daly (336830), William Bernal (336841), Nizar Drou (336839), Mario Caccamo (42188), Antonia P. Mayer (336837), Graeme J. M. Alexander (336840), Anne Palser (336838), Nick Bexfield (336832), Judith Heaney (336834), Laurence Tiley (29876), Jonathan L. Heeney (172149) +12 morecore +1 more source